These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 26154007)

  • 1. Public biotech in 2014--the numbers.
    Morrison C; Lähteenmäki R
    Nat Biotechnol; 2015 Jul; 33(7):703-9. PubMed ID: 26154007
    [No Abstract]   [Full Text] [Related]  

  • 2. Public biotech 2012--the numbers.
    Huggett B
    Nat Biotechnol; 2013 Aug; 31(8):697-703. PubMed ID: 23929343
    [No Abstract]   [Full Text] [Related]  

  • 3. Public biotech in 2015 - the numbers.
    Morrison C; Lähteenmäki R
    Nat Biotechnol; 2016 Jul; 34(7):709-15. PubMed ID: 27404879
    [No Abstract]   [Full Text] [Related]  

  • 4. Public biotech 2018-the numbers.
    Morrison C; Lähteenmäki R
    Nat Biotechnol; 2019 Jul; 37(7):714-721. PubMed ID: 31227821
    [No Abstract]   [Full Text] [Related]  

  • 5. Public biotech 2008--the numbers.
    Huggett B; Hodgson J; Lähteenmäki R
    Nat Biotechnol; 2009 Aug; 27(8):710-21. PubMed ID: 19668175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Public biotech 2009-the numbers.
    Huggett B; Hodgson J; Lähteenmäki R
    Nat Biotechnol; 2010 Aug; 28(8):793-9. PubMed ID: 20697401
    [No Abstract]   [Full Text] [Related]  

  • 7. Biotech R&D still reeling.
    Lawrence S
    Nat Biotechnol; 2004 Sep; 22(9):1068. PubMed ID: 15340460
    [No Abstract]   [Full Text] [Related]  

  • 8. Public companies get creative in raising finance.
    Hodgson J
    Nat Biotechnol; 2010 Apr; 28(4):301-2. PubMed ID: 20379161
    [No Abstract]   [Full Text] [Related]  

  • 9. Public biotech 2010--the numbers.
    Huggett B; Hodgson J; Lähteenmäki R
    Nat Biotechnol; 2011 Jul; 29(7):585-91. PubMed ID: 21747381
    [No Abstract]   [Full Text] [Related]  

  • 10. Public biotechnology 2005--the numbers.
    Lähteenmäki R; Lawrence S
    Nat Biotechnol; 2006 Jun; 24(6):625-34. PubMed ID: 16763588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Public biotech 2011--the numbers.
    Huggett B; Lähteenmaki R
    Nat Biotechnol; 2012 Aug; 30(8):751-7. PubMed ID: 22871710
    [No Abstract]   [Full Text] [Related]  

  • 12. Bid to limit prices on drugs using 'public' discoveries.
    Wadman M
    Nature; 1998 May; 393(6683):297. PubMed ID: 9620788
    [No Abstract]   [Full Text] [Related]  

  • 13. Reducing the burden of disclosure for public biotech companies.
    Evans R; Kessel M
    Nat Biotechnol; 2014 May; 32(5):419-20. PubMed ID: 24811509
    [No Abstract]   [Full Text] [Related]  

  • 14. Public biotech 2013--the numbers.
    Lawrence S; Lahteenmaki R
    Nat Biotechnol; 2014 Jul; 32(7):626-32. PubMed ID: 25004227
    [No Abstract]   [Full Text] [Related]  

  • 15. Wrong numbers?
    Nat Biotechnol; 2010 Aug; 28(8):761. PubMed ID: 20697382
    [No Abstract]   [Full Text] [Related]  

  • 16. Public biotech 2006 - the numbers.
    Lähteenmäki R; Lawrence S
    Nat Biotechnol; 2007 Jul; 25(7):729-37. PubMed ID: 17621294
    [No Abstract]   [Full Text] [Related]  

  • 17. From the analyst's couch: The outlook for biotech exits.
    Grimaldi A
    Nat Biotechnol; 2014 Mar; 32(3):227-8. PubMed ID: 24727772
    [No Abstract]   [Full Text] [Related]  

  • 18. Human genomes, public and private.
    Nature; 2001 Feb; 409(6822):745. PubMed ID: 11236960
    [No Abstract]   [Full Text] [Related]  

  • 19. A lifeline for the biotech sector.
    Kessel M
    Nat Biotechnol; 2009 Feb; 27(2):123-4. PubMed ID: 19204686
    [No Abstract]   [Full Text] [Related]  

  • 20. Public sector seeks to bridge 'valley of death'.
    Moran N
    Nat Biotechnol; 2007 Mar; 25(3):266. PubMed ID: 17344867
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.